Type 1 Diabetes
CGM use increases with expanded insurance coverage for insulin users
Health insurance policy changes that expand access to continuous glucose monitoring for adults with type 1 or type 2 diabetes can greatly increase uptake of the devices, according to a study published in Diabetes Technology & Therapeutics.
Time below range of 70 mg/dL can be used to estimate lower cutoff in type 1 diabetes
A strong correlation exists between time below range of 54 mg/dL and time below range of 70 mg/dL, though the difference between the two values varies based on continuous glucose monitoring type, according to study data.
Type 1 diabetes screening reaches ‘potentially pivotal moment’ with new treatment option
The benefits of type 1 diabetes screening have long been up for debate, but FDA approval of the first therapy to delay the disease’s onset may be changing the conversation.
Is universal screening for type 1 diabetes ready for prime time?
A few months ago, I would have questioned the value of universal screening for type 1 diabetes because we did not have anything to offer people who are at risk for the disease. However, we now have a drug — teplizumab-mzwv — that can delay the onset of type 1 diabetes. That is an important advance.
Effective disease management may help improve sleep quality among those with diabetes
Sleep quality in patients with type 1 diabetes may be improved with disease management as well as interventions supporting resilience and reducing negative emotions, researchers reported in BMC Psychiatry.
Intermittent-scanned CGM with low glucose alarms reduces hypoglycemia in type 1 diabetes
Switching to intermittent-scanned continuous glucose monitors with low glucose alarms reduced hypoglycemia frequency among middle-aged adults with type 1 diabetes, researchers reported.
Unique barriers for parents of children with type 1 diabetes in rural areas
Parents of children with type 1 diabetes living in rural areas report unique barriers to health care, including distance from support systems, unreliable technology resources and lack of diabetes understanding in the community, data show.
Top in endocrinology: Diabetes rates likely to rise in youth; new semaglutide indication
New data show that the number of youths with diabetes may increase from 185,000 with type 1 diabetes and 28,000 with type 2 diabetes in 2017 to 191,000 with type 1 diabetes and 48,000 with type 2 diabetes by 2060 if current trends continue.
Behavioral sleep intervention may improve sleep duration, regularity in type 1 diabetes
A technology-assisted behavioral sleep intervention was feasible and acceptable and may be effective for improving sleep duration or regularity for adults with type 1 diabetes, according to data from a pilot study.
Healthy management of type 1 diabetes in pregnancy begins before conception
Susan Weiner, MS, RDN, CDCES, FADCES, talks with Jennifer Smith, RD, LD, CDCES, to discuss steps women with type 1 diabetes can take to prepare for a healthy pregnancy.